
Patricia Ann Duffy
Examiner (ID: 7333)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1806, 1648, 1802, 1645, 1818 |
| Total Applications | 1671 |
| Issued Applications | 766 |
| Pending Applications | 244 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5845306
[patent_doc_number] => 20020132789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Nucleic acid vaccines against rickettsial diseases and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/062994
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6420
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132789.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062994 | Nucleic acid vaccines against rickettsial diseases and methods of use | Jan 30, 2002 | Issued |
Array
(
[id] => 6156714
[patent_doc_number] => 20020146411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Anticoagulant agents useful in treatment of thrombosis'
[patent_app_type] => new
[patent_app_number] => 10/051852
[patent_app_country] => US
[patent_app_date] => 2002-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16855
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051852 | Anticoagulant agents useful in treatment of thrombosis | Jan 16, 2002 | Abandoned |
Array
(
[id] => 6462344
[patent_doc_number] => 20020150579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'B lymphocyte stimulator (BLyS) as a marker in management of systemic lupus erythematosus'
[patent_app_type] => new
[patent_app_number] => 10/041663
[patent_app_country] => US
[patent_app_date] => 2002-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3388
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20020150579.pdf
[firstpage_image] =>[orig_patent_app_number] => 10041663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/041663 | B lymphocyte stimulator (BLyS) as a marker in management of systemic lupus erythematosus | Jan 9, 2002 | Abandoned |
Array
(
[id] => 390064
[patent_doc_number] => 07300659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-27
[patent_title] => 'Enterohemorrhagic Escherichia coli vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/039760
[patent_app_country] => US
[patent_app_date] => 2002-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13326
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/300/07300659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10039760
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/039760 | Enterohemorrhagic Escherichia coli vaccine | Jan 2, 2002 | Issued |
Array
(
[id] => 6778185
[patent_doc_number] => 20030049266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Immunomodulatory polynucleotides and methods of using the same'
[patent_app_type] => new
[patent_app_number] => 10/033243
[patent_app_country] => US
[patent_app_date] => 2001-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31362
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10033243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/033243 | Immunomodulatory polynucleotides and methods of using the same | Dec 26, 2001 | Abandoned |
Array
(
[id] => 5814781
[patent_doc_number] => 20060084590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Methods of and compounds for modulating the activity of bacterial FabG'
[patent_app_type] => utility
[patent_app_number] => 10/024808
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11754
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084590.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024808
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024808 | Methods of and compounds for modulating the activity of bacterial FabG | Dec 18, 2001 | Abandoned |
Array
(
[id] => 6046895
[patent_doc_number] => 20020168373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'House dust mite allergen, Der f VII, and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/024955
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16213
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024955
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024955 | House dust mite allergen, Der f VII, and uses therefor | Dec 18, 2001 | Issued |
Array
(
[id] => 6817701
[patent_doc_number] => 20030068659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'ICAM-4 materials and methods'
[patent_app_type] => new
[patent_app_number] => 10/025524
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17159
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10025524
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/025524 | ICAM-4 materials and methods | Dec 17, 2001 | Abandoned |
| 09/830779 | Method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure | Nov 29, 2001 | Abandoned |
Array
(
[id] => 7161083
[patent_doc_number] => 20050084853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Aspergillus fumigatus profilin'
[patent_app_type] => utility
[patent_app_number] => 10/432559
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16710
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432559
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432559 | Aspergillus fumigatus profilin | Nov 26, 2001 | Abandoned |
Array
(
[id] => 710296
[patent_doc_number] => 07056700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-06
[patent_title] => 'Use of ClyA hemolysin for excretion of proteins'
[patent_app_type] => utility
[patent_app_number] => 09/993292
[patent_app_country] => US
[patent_app_date] => 2001-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 13476
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/056/07056700.pdf
[firstpage_image] =>[orig_patent_app_number] => 09993292
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/993292 | Use of ClyA hemolysin for excretion of proteins | Nov 22, 2001 | Issued |
| 09/937052 | Fungal beta-tubulin genes | Nov 22, 2001 | Abandoned |
Array
(
[id] => 6813164
[patent_doc_number] => 20030072714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Microfluidized leishmania lysate and methods of making and using thereof'
[patent_app_type] => new
[patent_app_number] => 09/975020
[patent_app_country] => US
[patent_app_date] => 2001-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7490
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20030072714.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975020
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975020 | Microfluidized leishmania lysate and methods of making and using thereof | Oct 11, 2001 | Abandoned |
Array
(
[id] => 5985825
[patent_doc_number] => 20020098520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Cell tests and diagnostic index for alzheimer\'s disease'
[patent_app_type] => new
[patent_app_number] => 09/973404
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 21339
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098520.pdf
[firstpage_image] =>[orig_patent_app_number] => 09973404
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/973404 | Cell tests and diagnostic index for alzheimer's disease | Oct 8, 2001 | Abandoned |
Array
(
[id] => 4553586
[patent_doc_number] => 07838003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-23
[patent_title] => 'BASB205 polypeptides and polynucleotides from Haemophilus influenzae '
[patent_app_type] => utility
[patent_app_number] => 10/399089
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 23036
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/838/07838003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10399089
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/399089 | BASB205 polypeptides and polynucleotides from Haemophilus influenzae | Oct 4, 2001 | Issued |
Array
(
[id] => 6791977
[patent_doc_number] => 20030087321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Antimicrobial methods and materials'
[patent_app_type] => new
[patent_app_number] => 09/966521
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 14132
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087321.pdf
[firstpage_image] =>[orig_patent_app_number] => 09966521
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/966521 | Antimicrobial methods and materials | Sep 27, 2001 | Abandoned |
Array
(
[id] => 6530055
[patent_doc_number] => 20020136725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Antithrombotic agents'
[patent_app_type] => new
[patent_app_number] => 09/965099
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18717
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20020136725.pdf
[firstpage_image] =>[orig_patent_app_number] => 09965099
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/965099 | Antithrombotic agents | Sep 25, 2001 | Abandoned |
Array
(
[id] => 757238
[patent_doc_number] => 07014998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Screening immunomodulatory agents by CTLA-4 upregulation'
[patent_app_type] => utility
[patent_app_number] => 09/961503
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10486
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/014/07014998.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961503
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961503 | Screening immunomodulatory agents by CTLA-4 upregulation | Sep 23, 2001 | Issued |
Array
(
[id] => 6668367
[patent_doc_number] => 20030113350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Glycoconjugate vaccines for use in immune-compromised populations'
[patent_app_type] => new
[patent_app_number] => 09/955585
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8252
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113350.pdf
[firstpage_image] =>[orig_patent_app_number] => 09955585
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/955585 | Glycoconjugate vaccines for use in immune-compromised populations | Sep 18, 2001 | Abandoned |
Array
(
[id] => 393821
[patent_doc_number] => 07297514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-20
[patent_title] => 'Method for preventing superoxide damage to cells and oxygen-labile proteins'
[patent_app_type] => utility
[patent_app_number] => 09/955502
[patent_app_country] => US
[patent_app_date] => 2001-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 6621
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/297/07297514.pdf
[firstpage_image] =>[orig_patent_app_number] => 09955502
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/955502 | Method for preventing superoxide damage to cells and oxygen-labile proteins | Sep 17, 2001 | Issued |